-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On April 14, 2022, the internationally renowned journal Nature Communications published online the latest research results of Wang Yiguang's research team from the State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmacy, Peking University, "Dissecting extracellular and intracellular distribution of nanoparticles and their contribution to therapeutic response by "monochromatic ratiometric imaging" ( monochromatic ratiometric imaging technology to analyze the intracellular and extracellular distribution of nanomedicine and its contribution to the therapeutic effect)
In recent years, nanomedicines have received extensive attention in cancer treatment
Wang Yiguang's research team developed a pH/light dual-responsive monochromatic ratio imaging nanoparticle (MRIN) based on the group's existing pH-sensitive (Ultra-pH-sensitive, UPS) nanotechnology platform.
Using this technology, Wang Yiguang's research team successfully analyzed the contribution of extracellular nanophotosensitizers to tumor treatment
Researcher Wang Yiguang of Peking University School of Pharmacy is the corresponding author of this research paper
Paper link: https://
【Profile of Researcher Wang Yiguang】
Wang Yiguang, researcher and doctoral supervisor of Peking University, director of the Department of Pharmacy, School of Pharmacy, PI of the State Key Laboratory of Natural and Biomimetic Drugs
(School of Pharmacy, Peking University)